We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$939M
AUM Growth
+$86.2M
(+10%)
Cap. Flow
+$29.6M
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$5.37M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$2.54M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$2.12M |
| 5 |
NVIDIA
NVDA
|
+$1.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$6.88M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$4.62M |
| 3 |
Oaktree Specialty Lending
OCSL
|
+$825K |
| 4 |
MGI
MoneyGram International, Inc. New
MGI
|
+$627K |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$562K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.18% |
| 2 | Technology | 15.3% |
| 3 | Healthcare | 6.27% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Industrials | 3.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
ASE Group
ASX
$83.8B
| $16.2K | ﹤0.01% |
2,079
-47
| -2% | -$362 |
|
|
EXAS
1202
DELISTED
Exact Sciences
EXAS
| $16.2K | ﹤0.01% |
172
+55
| +47% | +$4.29K |
|
|
CCF
1203
DELISTED
Chase Corporation
CCF
| $16.1K | ﹤0.01% |
133
| – | – |
|
1204
United Natural Foods
UNFI
$2.82B
| $16.1K | ﹤0.01% |
823
+371
| +82% | +$9.32K |
|
|
ISEE
1205
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $16.1K | ﹤0.01% |
409
-15,932
| -97% | -$562K |
|
|
GLDD
1206
DELISTED
Great Lakes Dredge & Dock
GLDD
| $16.1K | ﹤0.01% |
1,969
+352
| +22% | +$2.29K |
|
1207
iShares Core S&P Total US Stock Market ETF
ITOT
$97.9B
| $16K | ﹤0.01% |
+164
| New | +$15.2K |
|
|
MOMO
1208
Hello Group
MOMO
$867M
| $16K | ﹤0.01% |
1,669
+34
| +2% | +$299 |
|
1209
Freshworks
FRSH
$3.28B
| $16K | ﹤0.01% |
911
| – | – |
|
1210
Blackbaud
BLKB
$2.1B
| $15.9K | ﹤0.01% |
224
+21
| +10% | +$1.48K |
|
1211
Bumble
BMBL
$366M
| $15.9K | ﹤0.01% |
949
+368
| +63% | +$6.36K |
|
1212
Equity Residential
EQR
$24.7B
| $15.9K | ﹤0.01% |
241
+85
| +54% | +$5.31K |
|
1213
Lithia Motors
LAD
$8.24B
| $15.8K | ﹤0.01% |
52
+9
| +21% | +$2.15K |
|
1214
B&G Foods
BGS
$277M
| $15.7K | ﹤0.01% |
1,128
-2,627
| -70% | -$37.8K |
|
1215
Performance Food Group
PFGC
$18B
| $15.7K | ﹤0.01% |
260
+5
| +2% | +$294 |
|
1216
Guardant Health
GH
$22.7B
| $15.6K | ﹤0.01% |
437
+169
| +63% | +$4.85K |
|
|
SNV
1217
DELISTED
Synovus
SNV
| $15.6K | ﹤0.01% |
517
+93
| +22% | +$2.72K |
|
1218
Omega Healthcare
OHI
$14.4B
| $15.6K | ﹤0.01% |
509
-18
| -3% | -$520 |
|
1219
Ares Management
ARES
$30.6B
| $15.6K | ﹤0.01% |
162
-9
| -5% | -$778 |
|
1220
Globe Life
GL
$14.4B
| $15.5K | ﹤0.01% |
141
-132
| -48% | -$14.2K |
|
1221
Kohl's
KSS
$2.17B
| $15.4K | ﹤0.01% |
669
+200
| +43% | +$4.33K |
|
1222
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.94B
| $15.4K | ﹤0.01% |
215
| – | – |
|
1223
Kinross Gold
KGC
$32.5B
| $15.4K | ﹤0.01% |
3,228
| – | – |
|
1224
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.73B
| $15.3K | ﹤0.01% |
209
| – | – |
|
1225
Fastly Inc
FSLY
$4.39B
| $15.3K | ﹤0.01% |
969
-15
| -2% | -$230 |
|
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.
- Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
- Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
- Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
- Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
- Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
- Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
- Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.
Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.